continues

Expert: Biogen Is Closing In On The 'Holy Grail' For Biotech Stocks …

Related BIIBBiogen Continues To Decline After Friday’s RoutDid The AAN Meeting Affect Biogen, PTC Therapeutics, GW Pharma Or Isis Pharma?Synageva Q1 Loss Narrower-than-Expected, Pipeline in Focus – Analyst Blog(Zacks)In this week’s episode, Estimize is joined by Joe McCann, a former biotech analyst at CR Intrinsic and the CEO of Slingshot Insights.In the episode, Joe discusses Biogen Inc (NASDAQ: BIIB) new […]